Ken Rhodes

Ken Rhodes is a highly experienced professional in the field of neuroscience and drug discovery, currently serving as Vice President of Research at Bristol Myers Squibb since July 2023. Rhodes has a robust background in various leadership roles within prominent pharmaceutical companies, including Vice President positions at Pfizer and Biogen Idec, as well as senior roles at Wave Life Sciences and Yumanity Therapeutics. As the Chief Scientific Officer at Yumanity Therapeutics and a former Research Fellow at Johnson & Johnson, Rhodes has demonstrated expertise in orchestrating scientific research aimed at treating chronic neurodegenerative diseases. Additionally, Rhodes is a small business owner at GaliptyLight, LLC, specializing in fine art city and landscape photography. Academic credentials include a Ph.D. in Anatomy and Neurobiology from Boston University and a BA in Psychology from Williams College.